In the analysis of CRP, enhanced CRP was related to shortened OS in patients with osteosarcoma (HR = 1.39, 95% CI: 1.06-1.83), and patients with other bone cancers encountered the same situation. The gene discussed is CRP; the disease is bone neoplasm.